USSTOCK.TODAY
Market Closed Log in Sign up

Pfizer counters patent cliff with 32% revenue growth from recent launches and acquisitions

The Motley Fool +1 · ·by G4L

PFE Pfizer Inc
$27.40 -0.51%
View chart & analysis →
  1. 1Pfizer's revenue from recent launches and acquisitions grew by 32% in the third quarter of 2026.
  2. 2Pfizer secured $1.8 billion in cash and $12.4 billion in short-term investments in the third quarter of 2026.
  3. 3Management supports dividends based on Pfizer's 85% cash dividend payout ratio.

So what's the key point?

Revenue from Pfizer's new or acquired drugs grew by 32%. The company holds significant cash to support dividend payments to shareholders.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →